Séverine Crettol

2.3k total citations
40 papers, 1.5k citations indexed

About

Séverine Crettol is a scholar working on Pharmacology, Pharmacology and Psychiatry and Mental health. According to data from OpenAlex, Séverine Crettol has authored 40 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pharmacology, 9 papers in Pharmacology and 9 papers in Psychiatry and Mental health. Recurrent topics in Séverine Crettol's work include Pharmacogenetics and Drug Metabolism (14 papers), Drug Transport and Resistance Mechanisms (8 papers) and Pharmacological Effects and Toxicity Studies (7 papers). Séverine Crettol is often cited by papers focused on Pharmacogenetics and Drug Metabolism (14 papers), Drug Transport and Resistance Mechanisms (8 papers) and Pharmacological Effects and Toxicity Studies (7 papers). Séverine Crettol collaborates with scholars based in Switzerland, Australia and United States. Séverine Crettol's co-authors include Chin B. Eap, Jacques Besson, Marina Croquette-Krokar, Robert Hämmig, Martine Monnat, Isabelle Gothuey, Nicolas Ansermot, Julien Déglon, Michael T. Murray and Beatrice Oneda and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and British Journal of Pharmacology.

In The Last Decade

Séverine Crettol

35 papers receiving 1.5k citations

Peers

Countries citing papers authored by Séverine Crettol

Since Specialization

Citations

This map shows the geographic impact of Séverine Crettol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Séverine Crettol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Séverine Crettol more than expected).

Fields of papers citing papers by Séverine Crettol

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Séverine Crettol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Séverine Crettol. The network helps show where Séverine Crettol may publish in the future.

Co-authorship network of co-authors of Séverine Crettol

This figure shows the co-authorship network connecting the top 25 collaborators of Séverine Crettol. A scholar is included among the top collaborators of Séverine Crettol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Séverine Crettol. Séverine Crettol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Self-reported caffeine consumption miss-matched consumption measured by plasma levels of caffeine and its metabolites: results from two population-based studies 2024 ·European Journal of Nutrition ·(unknown), Setareh Ranjbar, Marie‐Pierre F. Strippoli, Pedro Marques‐Vidal, (unknown), Belén Ponte, Menno Pruijm, Bruno Vogt, Nicolas Ansermot, Séverine Crettol, Frederik Vandenberghe, Péter Vollenweider, Martin Preisig, Murielle Bochud, Chin B. Eap	0
2	Identification of four novel loci associated with psychotropic drug-induced weight gain in a Swiss psychiatric longitudinal study: A GWAS analysis 2023 ·Molecular Psychiatry ·Jennifer Sjaarda, (unknown), (unknown), (unknown), (unknown), (unknown), Frederik Vandenberghe, Séverine Crettol, Nicolas Ansermot, Franziska Gamma, Kerstin Jessica Plessen, Armin von Gunten, Philippe Conus, Zoltán Kutalik, Chin B. Eap	8
3	Insomnia disorders are associated with increased cardiometabolic disturbances and death risks from cardiovascular diseases in psychiatric patients treated with weight-gain-inducing psychotropic drugs: results from a Swiss cohort 2022 ·BMC Psychiatry ·(unknown), (unknown), Setareh Ranjbar, (unknown), (unknown), (unknown), (unknown), Hélène Richard-Lepouriel, Nicolas Ansermot, Séverine Crettol, Frederik Vandenberghe, (unknown), (unknown), Franziska Gamma, Kerstin Jessica Plessen, Armin von Gunten, Philippe Conus, Chin B. Eap	12
4	Case Report: Opioid Use Disorder Associated With Low/Moderate Dose of Loperamide in an Intellectual Disability Patient With CYP3A and P-Glycoprotein Reduced Activity 2022 ·Frontiers in Psychiatry ·Vincent Guinchat, Nicolas Ansermot, Kuntheavy Ing Lorenzini, (unknown), Youssef Daali, Chin B. Eap, Séverine Crettol	1
5	Sorafenib N-Oxide Is an Inhibitor of Human Hepatic CYP3A4 2019 ·The AAPS Journal ·Sussan Ghassabian, (unknown), Tristan Rawling, Séverine Crettol, Pramod C. Nair, Michael T. Murray	10
6	Weighted Genetic Risk Scores and Prediction of Weight Gain in Solid Organ Transplant Populations 2016 ·PLoS ONE ·(unknown), Lina Quteineh, Pierre–Yves Bochud, Séverine Crettol, Zoltán Kutalik, Agnieszka Wójtowicz, Stéphanie Bibert, Sonja Beckmann, Nicolas J. Mueller, Isabelle Binet, Christian van Delden, Jürg Steiger, Paul Mohaçsi, Guido Stirnimann, Paola M. Soccal, Manuel Pascual, Chin B. Eap, (unknown)	8
7	CRTC2 polymorphism as a risk factor for the incidence of metabolic syndrome in patients with solid organ transplantation 2015 ·The Pharmacogenomics Journal ·Lina Quteineh, Pierre–Yves Bochud, Déla Golshayan, Séverine Crettol, Jean-Pierre Venetz, Oriol Manuel, Zoltán Kutalik, (unknown), Roger Lehmann, Nicolas J. Mueller, Isabelle Binet, Christian van Delden, Jürg Steiger, Paul Mohaçsi, Jean‐François Dufour, Paola M. Soccal, Manuel Pascual, Chin B. Eap, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	9
8	Pharmacogenomics in Psychiatry: From Therapeutic Drug Monitoring to Genomic Medicine 2013 ·Clinical Pharmacology & Therapeutics ·Séverine Crettol, José de León, Christoph Hiemke, Chin B. Eap	38
9	Contribution of CYP2B6 alleles in explaining extreme (S)-methadone plasma levels 2012 ·Pharmacogenetics and Genomics ·Maria Dobrinas, Séverine Crettol, Beatrice Oneda, (unknown), Margalida Rotger, Eva Choong, Rubin Lubomirov, Chantal Csajka, Chin B. Eap	39
10	β-Arrestin2 influences the response to methadone in opioid-dependent patients 2010 ·The Pharmacogenomics Journal ·Beatrice Oneda, Séverine Crettol, Murielle Bochud, Jacques Besson, Marina Croquette-Krokar, Robert Hämmig, Martine Monnat, Martin Preisig, Chin B. Eap	34
11	Participation of CYP2C8 and CYP3A4 in the N‐demethylation of imatinib in human hepatic microsomes 2010 ·British Journal of Pharmacology ·Noelia Nebot, Séverine Crettol, (unknown), Bruce N. Tattam, David E. Hibbs, Michael T. Murray	76
12	The P450 oxidoreductase genotype is associated with CYP3A activity in vivo as measured by the midazolam phenotyping test 2009 ·Pharmacogenetics and Genomics ·Beatrice Oneda, Séverine Crettol, (unknown), Murielle Bochud, Nicolas Ansermot, Chin B. Eap	96
13	ABCB1 and Cytochrome P450 Polymorphisms 2009 ·Journal of Clinical Psychopharmacology ·E Jaquenoud Sirot, (unknown), (unknown), (unknown), Beatrice Oneda, Séverine Crettol, Nicolas Ansermot, Pierre Baumann, Chin B. Eap	105
14	Cannabis and benzodiazepines as determinants of methadone trough plasma concentration variability in maintenance treatment: a transnational study 2009 ·European Journal of Clinical Pharmacology ·Richard Hallinan, Séverine Crettol, Kingsley Agho, John Attia, Jacques Besson, Marina Croquette-Krokar, Robert Hämmig, Jean‐Jacques Déglon, Andrew J. Byrne, John E. Ray, Andrew A. Somogyi, Chin B. Eap	10
15	Pharmacogenetics of Phase I and Phase II Drug Metabolism 2009 ·Current Pharmaceutical Design ·Séverine Crettol, Nenad Petrović, Michael T. Murray	71
16	CYP3A7, CYP3A5, CYP3A4, and ABCB1 Genetic Polymorphisms, Cyclosporine Concentration, and Dose Requirement in Transplant Recipients 2008 ·Therapeutic Drug Monitoring ·Séverine Crettol, Jean-Pierre Venetz, (unknown), John‐David Aubert, Manuel Pascual, Chin B. Eap	65
17	Stereoselective Block of hERG Channel by (S)-Methadone and QT Interval Prolongation in CYP2B6 Slow Metabolizers 2007 ·Clinical Pharmacology & Therapeutics ·Chin B. Eap, Séverine Crettol, Jean‐Sébastien Rougier, Jürg Schläpfer, Liliana Sintra Grilo, (unknown), Jacques Besson, Marina Croquette-Krokar, (unknown), Hugues Abriel	192
18	Increased (R)-Methadone Plasma Concentrations by Quetiapine in Cytochrome P450s and ABCB1 Genotyped Patients 2007 ·Journal of Clinical Psychopharmacology ·C. Uehlinger, Séverine Crettol, (unknown), (unknown), L. Koeb, Marlyse Brawand-Amey, Chin B. Eap	42
19	ABCB1 and cytochrome P450 genotypes and phenotypes: Influence on methadone plasma levels and response to treatment 2006 ·Clinical Pharmacology & Therapeutics ·Séverine Crettol, Julien Déglon, Jacques Besson, Marina Croquette-Krokar, Robert Hämmig, Isabelle Gothuey, Martine Monnat, Chin B. Eap	190
20	Methadone enantiomer plasma levels, CYP2B6, CYP2C19, and CYP2C9 genotypes, and response to treatment 2005 ·Clinical Pharmacology & Therapeutics ·Séverine Crettol, Julien Déglon, Jacques Besson, (unknown), Isabelle Gothuey, Robert Hämmig, Martine Monnat, (unknown), Pierre Baumann, Chin B. Eap	187

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact